Stock Research: Boiron

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Boiron

ENXTPA:BOI FR0000061129
44
  • Value
    84
  • Growth
    5
  • Safety
    Safety
    100
  • Combined
    82
  • Sentiment
    11
  • 360° View
    360° View
    44
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Boiron SA is a French pharmaceutical company providing homeopathic medicines. It operates in the pharmaceutical industry, developing and marketing single homeopathic medicines, drugs, and health and beauty care products. Subsidiaries are located in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada, and Brazil, among others. In the last fiscal year, the company had a market cap of $458 million, profits of $371 million, revenue of $505 million, and 2771 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 44 (better than 44% compared with alternatives), overall professional sentiment and financial characteristics for the stock Boiron are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Boiron. The consolidated Value Rank has an attractive rank of 100, which means that the share price of Boiron is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 100% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 84. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 11. Professional investors are more confident in 89% other stocks. The consolidated Growth Rank also has a low rank of 5, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 95 of its competitors have better growth. ...read more

more
Index
CAC All
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 100 89 100
Growth
5 23 45 7
Safety
Safety
84 95 96 94
Sentiment
11 15 22 16
360° View
360° View
44 78 84 58
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
7 7 11 43
Opinions Change
2 2 50 50
Pro Holdings
n/a 43 43 38
Market Pulse
1 1 61 11
Sentiment
11 15 22 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 100 89 100
Growth
5 23 45 7
Safety Safety
84 95 96 94
Combined
82 95 100 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
90 84 62 80
Price vs. Earnings (P/E)
84 80 76 87
Price vs. Book (P/B)
92 86 83 90
Dividend Yield
99 98 82 74
Value
100 100 89 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
30 27 39 24
Profit Growth
13 39 54 15
Capital Growth
22 40 19 14
Stock Returns
13 17 68 50
Growth
5 23 45 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
82 89 86 81
Refinancing
83 73 85 86
Liquidity
53 86 85 81
Safety Safety
84 95 96 94

Similar Stocks

Discover high‑ranked alternatives to Boiron and broaden your portfolio horizons.

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Savencia

ENXTPA:SAVE
Country: France
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Societe Generale

ENXTPA:GLE
Country: France
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.